EI
HAE icon

Ellevest Inc’s Haemonetics HAE Stock Holding History

Ellevest Inc’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed -$166 – 881
2023
Q1 		$166 Sell
2
-7
-78% -$567 ﹤0.01% 1781
2022
Q4 		$708 Buy
+9
New +$723 ﹤0.01% 1572
2022
Q2 		– Sell
-3
Closed – – 1506
2022
Q1 		$0 Buy
+3
New +$163 ﹤0.01% 1501
2021
Q4 		– Sell
-26
Closed -$2K – 1515
2021
Q3 		$2K Buy
+26
New +$1.64K ﹤0.01% 1140
2021
Q2 		– Sell
-6
Closed -$1K – 1325
2021
Q1 		$1K Hold
6
– – ﹤0.01% 1162
2020
Q4 		$1K Hold
6
– – ﹤0.01% 1064
2020
Q3 		$1K Sell
6
-52
-90% -$4.54K ﹤0.01% 1014
2020
Q2 		$5K Buy
+58
New +$5.86K ﹤0.01% 741

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ellevest Inc's HAE Position: Q2 2023 in Review

Ellevest Inc sold out of Haemonetics (HAE) in Q2 2023, closing a stake of 2 shares — an estimated $166 sold.

Ellevest Inc first reported a position in HAE in Q2 2020 and held it in 8 quarters. The position peaked at $5K in Q2 2020. 294 funds tracked by Wall St. Rank hold HAE as of Q2 2023.

  • Ellevest Inc reported no remaining Haemonetics position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 2 Haemonetics shares in Q2 2023, an estimated $166.
  • Ellevest Inc first reported a position in Haemonetics in Q2 2020 and held it in 8 quarters.
  • Ellevest Inc's Haemonetics position peaked at $5K in Q2 2020.
  • 294 funds tracked by Wall St. Rank held Haemonetics as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.